The FDA’s Vaccines and Related Biological Products Advisory Committee urged manufacturers to remove the influenza B Yamagata lineage strain from next season’s flu shots during a March 5 meeting. The flu type B lineage hasn’t been detected globally since March 2020 and no longer poses a threat to public health, the committee said.
The move marks a return to trivalent vaccines after more than a decade — the FDA approved the first quadrivalent flu vaccine that includes the second type B strain in 2012.
The FDA said it’s working with manufacturers to have “an adequate and diverse supply” of trivalent flu shots ready for next flu season.
Learn more here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
